The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Yigal Arnon & Co

Work +972 3 608 7777
Fax +972 3 608 7724
Jerusalem, Tel Aviv

Daniel Green

Work +972 2 6239200
Yigal Arnon & Co

Work Department

Asia Practice Group, High-Tech, Life Sciences, Technology and Transactional IP, Venture Capital and Private Equity.


Daniel Green's practice focuses on licensing, corporate partnering and intellectual property. Daniel has represented emerging and established technology companies in the information technology, e-commerce, biotechnology, medical device and pharmaceutical industries. Daniel has extensive experience in structuring, negotiating and documenting complex licensing, development and technology transfer arrangements, Internet and e-commerce agreements, OEM, VAR and other distribution and supply arrangements, joint ventures and other commercial transactions. Daniel also advises venture capital funds and has been involved with secondary fund transactions and various aspects of fund formation.


Prior to joining Yigal Arnon & Co., Daniel practiced law in Toronto, Canada, for a number of years with Cassels Brock & Blackwell LLP. Daniel has been a guest lecturer at the Hebrew University Law School in Jerusalem and at a continuing education program sponsored by the Israel Bar, and has been published in a leading international intellectual property periodical. Daniel joined the firm in 2003 and became a partner in 2012.


Daniel is fluent in English, Hebrew and French.


Daniel was admitted to the Law Society of Upper Canada (Ontario) in 1998 and to the Israel Bar in 2003.


Daniel earned his law degree at Osgoode Hall Law School of York University in Toronto. He also holds a B.A.(hon.) in Political Science from McGill University in Montreal and an M.A. (magna cum laude) in Middle East History from Tel Aviv University.


Healthcare and life sciences

Within: Healthcare and life sciences

Yigal Arnon & Co is involved in many of the largest cross-border M&A in Israel’s healthcare sector. Daniel Green advises Oramed Pharmaceuticals on commercial licensing transactions and cross-border partnership agreements. Yoheved Novogroder-Shoshan and Barry Levenfeld act for biotech incubators such as FutuRx and MEDX Xelerator.

[back to top]

Israel: Intellectual property


Within: Commercial/transactions

The IP group at Yigal Arnon & Co has experience in commercial and corporate IP agreements involving healthcare and medical devices, IT and data, and media and entertainment. Barry Levenfeld and Daniel Green have handled some of Israel’s largest tech-driven M&A and development transactions, and Eli Greenbaum has expertise in open source software licensing.

[back to top]

IHL Briefings

If your firm wishes to publish IHL Briefings or articles, please contact Antony Dine on +44 (0) 207 396 9315 or


The revolution in food and agricultural technology is only beginning

July 2017. By Daniel Green

In 2009, the UN-FAO released a report predicting that the worldÂ’s population would grow 34% by 2050. Among the many challenges posed by a growing world population, a primary challenge will be to ensure an adequate food supply for this vast population. This challenge is further complicated as the predominance of population growth will occur in regions of the world where food security issues are already rampant. The predicted increase in global demand for food has brought the agricultural and food production industries into the spotlight. As a global community, we will not only need to find ways to produce enough food to feed a growing world population, but we will need do so in a way that is sustainable and economically viable. [Continue Reading]

Back to index

Legal Developments by:
Yigal Arnon & Co

  • Israel Chapter in The Virtual Currency Regulation Review

    Earlier this year, the Israel Tax Authority (ITA) issued two circulars, one on the taxation of digital tokens and the second addressing the taxation of utility tokens in initial coin offerings (ICOs). Additionally, in March, the Israel Securities Authority (ISA) released a detailed interim report by the Committee for the Regulation of Public Offerings of Decentralized Cryptocurrency Coins (Report) (with a follow-up report due to come out around October 2018). Moreover, it is expected that before the end of 2018, legislation will come into force that for the first time will see Israeli primary legislation define virtual currencies as financial assets and mandate licensing for related services, as is later discussed in detail.
    - Yigal Arnon & Co

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to